Changes in synaptic expression of clathrin assembly protein AP180 in Alzheimer's disease analysed by immunohistochemistry
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Clathrin assembly protein AP180 plays a regulatory role in clathrin-mediated synaptic vesicle recycling in synapses. Previously, using immunoblot analysis, we observed a significant reduction of AP180 protein in Alzheimer's disease neocortex. In this study, we examined immunohistochemically the expression of AP180 in post mortem brains with Alzheimer's disease (n = 5) in comparison with neurologically normal controls (n = 5). Overall, AP180 was revealed as immunoreactive punctate granules located in the neuropil, and around neuronal cell bodies and their processes, consistent with the typical expression of synaptic proteins. Reduced density of AP180 immunoreactive puncta was seen throughout all layers of the superior frontal gyrus in Alzheimer's disease, but the loss of AP180 immunoreactivity was not as prominent in the cerebellum. This regional difference is in agreement with our previous results from immunoblot analyses. In the hippocampus, cell body AP180 immunoreactivity normally seen in the hilus and the CA3 regions of control brains was completely lost in Alzheimer's disease. In addition, AP180 immunoreactivity in the molecular layer of the dentate gyrus showed several changes in Alzheimer's disease. These appeared to be expansion of the inner molecular layer and relative changes in immunoreactivity that resulted in clearer delineation of the inner and outer molecular layers. These results provide anatomical and spatial information on AP180 expression in Alzheimer's disease brains. The variations in altered AP180 immunoreactivity in different brain regions of Alzheimer's disease may underlie the dysfunction of the corresponding synapses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Zhang, B., Koh, Y. H., Beckstead, R. B., Budnik, V., Ganetzky, B., & Bellen, H. J. (1998) · Neuron · doi:10.1016/s0896-6273(00)80664-9 · Cited by 434
Synaptic loss in Alzheimer's disease and other dementias
Hamos, J. E., DeGennaro, L. J., & Drachman, D. A. (1989) · Neurology · doi:10.1212/wnl.39.3.355 · Cited by 432
Clathrin assembly protein AP-3 is phosphorylated and glycosylated on the 50-kDa structural domain
Murphy, J. E., Hanover, J. A., Froehlich, M., DuBois, G., & Keen, J. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31968-3 · Cited by 54
Cited by
Biological Basket Weaving: Formation and Function of Clathrin-Coated Vesicles
Brodsky, F. M., Chen, C.-Y., Knuehl, C., Towler, M. C., & Wakeham, D. E. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.517 · Cited by 637
Synaptic degeneration in Alzheimer's disease
Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517
“Defects in synaptic transmission, furthermore, occur in AD well before the formation of amyloid plaques Table 1 Alterations of synaptic proteins in AD Loss of molecular components of presynaptic membranes GAP-43, SNAP-25, syntaxin [33, 38, 46, 59, 133, 194, 206, 207, 221] Loss of molecular components of synaptic vesic…”
Colangelo, V., Schurr, J., Ball, M. J., Pelaez, R. P., Bazan, N. G., & Lukiw, W. J. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10351 · Cited by 517
“Classically, NFT and A densities were correlated with AD progression and severity; however, more recent immunocytologic evidence suggests that distortion of neuronal shape, loss of functional synaptic contacts, and synapse-specific proteins may be more relevant pathologic markers (Scheff and Price, 1998; Kaufmann et a…”
BackgroundA focus on the synapse for neuroprotection in Alzheimer disease and other dementias
Coleman, P., Federoff, H., & Kurlan, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140626.48118.0a · Cited by 314
Self-citationPedersen, A. F., Meyer, D. N., Petriv, A.-M. V., Soto, A. L., Shields, J. N., Akemann, C., Baker, B. B., Tsou, W.-L., Zhang, Y., & Baker, T. R. (2020) · Environmental Pollution · doi:10.1016/j.envpol.2020.115090 · Cited by 162
Metadata
- Authors
- Yao, P. J., Morsch, R., Callahan, L. M., & Coleman, P. D.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1999-09
- Volume
- 94
- Issue
- 2
- Pages
- 389-394
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2047041100
- Cited by
- 48
- References
- 4
- FWCI
- 1.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes in synaptic expression of clathrin assembly protein AP180 in Alzheimer's disease analysed by immunohistochemistry. https://app.cochat.ai/papers/10.1016/s0306-4522(99)00360-7
- The paper
- Yao, P. J., Morsch, R., Callahan, L. M., & Coleman, P. D. (1999). Changes in synaptic expression of clathrin assembly protein AP180 in Alzheimer's disease analysed by immunohistochemistry. Neuroscience. https://doi.org/10.1016/s0306-4522(99)00360-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.